UK markets open in 5 hours 9 minutes
NIKKEI 225
39,379.38 +592.00 (+1.53%) HANG SENG
19,646.38 +92.77 (+0.47%) CRUDE OIL
80.05 -0.01 (-0.01%) GOLD FUTURES
2,435.90 +18.50 (+0.77%) DOW
40,003.59 +134.19 (+0.34%) Bitcoin GBP
52,296.71 -382.79 (-0.73%)
CLRB Aug 2024 7.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:34AM EDT. Market open.
| Previous close | 0.2000 |
| Open | 0.3900 |
| Bid | 0.0000 |
| Ask | 0.5500 |
| Strike | 7.50 |
| Expiry date | 2024-08-16 |
| Day's range | 0.2000 - 0.3900 |
| Contract range | N/A |
| Volume | |
| Open interest | 25 |
- Thomson Reuters StreetEvents
Q1 2024 Cellectar Biosciences Inc Earnings Call
Q1 2024 Cellectar Biosciences Inc Earnings Call
- GuruFocus.com
Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes and strategic initiatives as CLRB advances its clinical and commercial efforts.
GlobeNewswireCellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
Management to host a conference call today at 8:30 am ET WM pivotal study data to be announced in June FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced financial results for the quarter ended March 31, 2024, and provided a corporate update. “We plan to announce data from our CLOVER WaM pi
© 2024 Yahoo. All rights reserved.